Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450

Drug Metabolism and Disposition

Volumn 24, Issue 4, 1996, Pages 401-407

  Sewer, Marion B ^a   Koop, Dennis R ^b   Morgan, Edward T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; LAURIC ACID; MESSENGER RNA; OXYGENASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ENDOTOXEMIA; GENE EXPRESSION; GENE REPRESSION; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALKANE 1-MONOOXYGENASE; ANIMALS; BLOTTING, WESTERN; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; ESCHERICHIA COLI; ISOENZYMES; LIPOPOLYSACCHARIDES; LIVER; MALE; MIXED FUNCTION OXYGENASES; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TOXEMIA;

EID: 0029988591     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. G. Schreiber, G. Hewlett, M. Nagashima, A. Millership, H. Martin, J. Urban, and L. Kotler: The acute phase response of plasma protein synthesis during experimental inflammation. J. Biol. Chem. 257, 10271-10277 (1982).
2. H. Baumann, G. P. Jahreis, D. N. Sauder, and A. Koj: Human keritinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat, and mouse. J. Biol. Chem. 259, 7331-7342 (1984).
3. D. M. Bissel and L. E. Hammaker: Cytochrome P450 heme and the regulation of hepatic heme oxygenase activity. Arch. Biochem. Biophys 176, 91-102 (1976).
4. R. Gorodischer, J. Lrasner, J. J. McDevitt, J. P. Nolan, and S. J. Yaffe: Hepatic microsomal drug metabolism after administration of endotoxin in rats. Biochem. Pharmacol. 25, 351-353 (1976).
5. K. W. Renton: Factors affecting drug biotransformation. Clin. Biochem. 19, 72-75 (1986).
6. J. L. Mahu and G. Feldman: Study of biochemical behavior of some exported and nonexported hepatic proteins during acute inflammation reaction in the rat. Enzyme 31, 234-240 (1984).
7. S. I. Shedlofsky, B. C Israel, C. J. McClain, D. B. Hill, and R. A. Blouin: Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. J. Clin. Invest. 94, 2209-2214 (1994)
8. E. T. Morgan: Suppression of constitutive cytochrome P450 gene expression in livers of rats undergoing acute phase response to endotoxin. Mol. Pharmacol. 36, 699-707 (1989).
9. K. Wright and E. T. Morgan: Transcriptional and post-transcriptional suppression of P450IIC11 and P450IIC12 by inflammation. FEBS Lett. 271, 59-61 (1990).
10. E. T. Morgan. Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Biochem. Pharmacol. 45, 415-419 (1993).
11. K. Kurokohchi, H. Yoneyama, Y. Matsuo, M. Nishioka, and Y. Ichikawa: Effects of interleukin-1α on the activities and gene expression of the cytochrome P450HD subfamily. Biochem. Pharmacol. 44, 1669-1674 (1992).
12. Y. L. Chen, I. Florentin, A. M. Batt, L. Ferrari, J. P. Giroud, and L. Chauvelot-Moachon: Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. Biochem. Pharmacol. 44, 137-148 (1992).
13. E T. Morgan, K. B. Thomas, R. Swanson, T. Vales, J. Hwang, and K. Wright: Selective suppression of cytochrome P450 gene expression by interleukins 1 and 6 in rat liver. Biochim. Biophys. Acta 1219, 475-483 (1994).
14. J.-Q. Chen, A. Ström, J.-Å. Gustafsson, and E. T. Morgan: Suppression of the constitutive expression of cytochrome P4502C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Mol. Pharmacol. 47, 940-947 (1995).
15. E. T. Morgan and C. A. Norman: Pretranslational suppression of cytochrome P450h(IIC11) gene expression in rat liver after administration of interferon inducers. Drug Metab. Dispos. 18, 649-653 (1989).
16. P. I. Craig, I. Mehta, M. Murray, D. McDonald, A. Astrom, P. H. Meide, and G. C. Farrell: Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver. Mol. Pharmacol. 38, 313-318 (1990).
17. A. E. Cribb, E. Delaporte, S. G. Kim, R. F. Novak, and K. W. Renton: Regulation of cytochrome P4501A and cytochrome P4502E induction in the rat during the production of interferon α/β. J. Pharmacol. Exp. Ther. 268, 487-494 (1994).
18. D.A. Haugen and M.J. Coon: Properties of electrophoretically homogeneous phenobarbital-inducible froms of liver microsomal cytochrome P450. J. Biol. Chem. 251, 7929-7939 (1976).
19. P. Chomczynski and N. Sacchi: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
20. J. Sambrook, E. F. Fritsch, and T. Maniatis: In "Molecular Cloning, A Laboratory Manual", ed. 2, vol 1. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989.
21. V. Barbu and F. Dautry: Northern blot normalization with a 28S rRNA probe. Nucleic Acids Res. 17, 7115 (1989).
22. S. Kimura, J. P. Hardwick, C. A. Kozak, and F. J. Gonzalez: The rat clofibrate-inducible CYP4A subfamily II. cDNA sequence of IVA3. mapping of the Cyp4A locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes. DNA 8, 517-525 (1989).
23. S. S. Sundseth and D. J. Waxman: Sex dependent expression and clofibrate inducibility of cytochrome P4504A fatty acid omega hydroxylases. J. Biol. Chem. 267, 3915-3921 (1992).
24. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall: Protein measurement with the Folin phenol reagent. J Biol. Chem. 193, 265-275 (1951).
25. T. Omura and R. Sato: The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein in nature. J. Biol. Chem. 239, 2370-2378 (1964).
26. R. T. Okita, J. E. Clark, J. R. Okita, and B. S. S. Masters: Omega and (omega-1)-hydroxylation of eicosanoids and fatty acids by high-performance liquid chromatography. Methods Enzymol. 206, 432-441 (1991)
27. R. M. Laethem and D. R. Koop: Identification of rabbit cytochrome P450 2C1 and 2C2 as arachidonic acid epoxygenases. Mol. Pharmacol. 42, 958-963 (1992).
28. R. M. Laethem, C. L. Laethem, and D. R. Koop: Purification and properties of a cytochrome P450 arachidonic acid epoxygenase from rabbit renal cortex. J. Biol. Chem. 267, 5552-5559 (1992).
29. E. Eliasson, S. Mkrtchian, and M. Ingelman-Sundberg: Hormone- and substrate-regulated intracellular degradation of cytochrome P450(2E1) involving MgATP-activated rapid proteolysis in the endoplasmic reticulum membranes. J. Biol. Chem. 267, 15765-15769 (1992).
30. J. R. Okita, P. J. Castle, and R. T Okita: Characterization of cytochromes P450 in liver and kidney of rats treated with di-(2-ethylhexyl (phthalate. J. Biochem. Toxicol. 8, 135-144 (1993).
31. H. A. A. M. Dirven, A A. G. M. DeBruijn, P. J. M. Sessink, and F. J. Jongeneelen: Determination of the cytochrome P450 IV marker omegahydroxylauric acid, by high performance liquid chromatography and fluorimetric detection. J. Chromatogr. 564, 266-271 (1991).
32. S E. Clarke, S. J. Baldwin, J. C. Bloomer, A. D. Ayrton, R. S. Sozio, and R. J. Chenery: Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes. Chem. Res. Toxicol. 7, 836-842 (1994).
33. E.T. Morgan: Suppression of P4502C12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer poly rI.poly rC. Biochem. Pharmacol. 42, 51-57 (1991).
34. H. Sakai, T. Okamoto, and Y. Kikkawa: Suppression of hepatic drug metabolism by the Interferon inducer, polyriboinosinic acid:polyribocitidylic acid. J. Pharmacol. Exp. Ther. 263, 381-386 (1992).
35. L. C. Knickle, D. Spencer, and K. W. Renton: The suppression of hepatic cytochrome P4504A mRNA mediated by the Interferon inducer polyinosinic acid-polycytidylic acid. Biochem. Pharmacol. 44, 604-608 (1992).
36. J. A. Hewett, A. E. Schueltze, S. VanCise, and R. A. Roth: Neutrophil depletion protects against liver injury from bacterial endotoxin. Lab. Invest. 66, 347-361 (1992).
37. Y. Amet, F. Berthou, T. Goasduff, J. P. Salaun, L. Le Breton, and J. F. Menez: Evidence that cytochrome P4502E1 is involved in the (omega-1)-hydroxylation of lauric acid in rat liver microsomes. Biochem. Biophys. Res. Commun. 203, 1168-1174 (1994).
38. N. Shimojo, T. Ishizaki, S. Imaoka, Y. Funae, S. Fujii, and K Okuda: Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozotocin-induced diabetes. Biochem. Pharmacol. 46, 621-627 (1993).
39. A. S. Muerhoff, K. J. Griffin, and E. F. Johnson: The peroxisome-proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid ω-hydroxylase, by clofibric acid. J. Biol. Chem. 267, 19051-19053 (1992).
40. J. D. Tugwood, I. Issemann, R. G. Anderson, K. R. Bundell, W. L. McPheat. and S. Green: The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11, 433-439 (1992).
41. I. Issemann, R. Prince, J. Tugwood, and S. Green: A role for fatty acid binding protein in peroxisome proliferation? Biochem. Soc. Trans. 20, 824-827 (1992)
42. M. N. Milton, C. R. Elcombe, and G. G. Gibson: On the mechanism of microsomal cytochrome P450IVA1 and peroxisome proliferation in rat liver by clofibrate. Biochem Pharmacol. 40, 2727-2732 (1990).
43. 2- channel blockers. Biochem. J. 301, 753-758 (1994).
44. S. Kitagawa, Y. Yamaguchi, N. Imaizumi, M. Kumtomo, and M. Fujiwara: A uniform alteration in serum lipid metabolism occurring during inflammation in mice. Jpn. J. Pharmacol. 58, 37-46 (1992).
45. G. Singh, C. D. Hanevold, and I. Singh: Impairment of peroxisomal β-oxidation system by endotoxin treatment. Mol. Cell. Biochem. 135, 187-193 (1994).
46. V. Blank, P. Kourilsky, and A. Israel: NF-kB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends. Biochem. Sci. 17, 135-140, (1992).
47. J. H. Capdevila, J. R. Falck, and R. W. Estabrook: Cytochrome P450 and the arachidonate cascade. FASEB J. 6, 731-736. (1992).
48. D. R. Harder, W. B Campbell, and R. J. Roman: Role of cytochrome P450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res. 32, 79-92 (1995).
49. J. A. Hewett and R. A. Roth: Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol. Rev. 45, 381-411 (1993).
50. B.-J. Song, R. L. Veech, S. S. Park, H. V. Gelboin, and F. J. Gonzalez: Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization. J. Biol. Chem. 264, 3568-3572 (1989).
51. B. J. Roberts, S. E. Shoaf, K. S. Jeong, and B. J. Song: Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less. Biochem. Biophys. Res. Commun. 205, 1064-1071 (1994).
52. E. Eliasson, I. Johansson, and M. Ingelman-Sundberg. Substrate-, hormone-, and cAMP-regulated cytochrome P450 degradation Proc. Natl. Acad. Sci. U.S.A. 87, 3225-3229 (1990).